UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Predictors of adherence and the role of primary non-adherence in antihormonal treatment of breast cancer

BMC cancer, 2022-12, Vol.22 (1), p.1-1247, Article 1247

2022

Link zum Volltext

Verfügbarkeit prüfen

Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies

Cancer and metastasis reviews, 2021-03, Vol.40 (1), p.319-339

2021

Link zum Volltext

Verfügbarkeit prüfen

Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review

BMC cancer, 2023-07, Vol.23 (1), p.625-625, Article 625

2023

Link zum Volltext

Verfügbarkeit prüfen

The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients

International Journal of Molecular Sciences, 2015-10, Vol.16 (10), p.24243-24275

2015

Link zum Volltext

Verfügbarkeit prüfen

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial

BMC cancer, 2019-11, Vol.19 (1), p.1076-1076, Article 1076

2019

Link zum Volltext

Verfügbarkeit prüfen

Generating a Precision Endoxifen Prediction Algorithm to Advance Personalized Tamoxifen Treatment in Patients with Breast Cancer

Journal of personalized medicine, 2021-03, Vol.11 (3), p.201

2021

Link zum Volltext

Verfügbarkeit prüfen

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study

BMC cancer, 2019-12, Vol.19 (1), p.1183-1183, Article 1183

2019

Link zum Volltext

Verfügbarkeit prüfen

Thyroidectomy for Euthyroid Patients with Hashimoto Disease and Persistent Symptoms: An Observational, Postrandomization Study

Journal of thyroid research, 2024-04, Vol.2024, p.5518720-5518720

2024

Link zum Volltext

Verfügbarkeit prüfen

Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen

Molecular oncology, 2021-04, Vol.15 (4), p.957-967

2021

Link zum Volltext

Verfügbarkeit prüfen

Biologic profiling of lymph node negative breast cancers by means of microRNA expression

Modern pathology, 2010-12, Vol.23 (12), p.1567-1576

2010

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients

The journal of clinical endocrinology and metabolism, 2022-04, Vol.107 (5), p.1368-1374

2022

Link zum Volltext

Verfügbarkeit prüfen

Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort

Clinical pharmacology and therapeutics, 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

Illness uncertainty in breast cancer patients: Validation of the 5-item short form of the Mishel Uncertainty in Illness Scale

European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2015-04, Vol.19 (2), p.113-119

2015

Link zum Volltext

Verfügbarkeit prüfen

Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial

NPJ breast cancer, 2021-03, Vol.7 (1), p.34-34, Article 34

2021

Link zum Volltext

Verfügbarkeit prüfen

Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment

Breast cancer research and treatment, 2013-09, Vol.141 (2), p.243-248

2013

Link zum Volltext

Verfügbarkeit prüfen

In Patients Younger Than Age 55 Years With Lymph Node–Negative Breast Cancer, Proliferation by Mitotic Activity Index Is Prognostically Superior to Adjuvant

Journal of clinical oncology, 2011-03, Vol.29 (7), p.852-858

2011

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients

PloS one, 2017-03, Vol.12 (3), p.e0171453-e0171453

2017

Link zum Volltext

Verfügbarkeit prüfen

Fatigue, anxiety and depression overrule the role of oncological treatment in predicting self-reported health complaints in women with breast cancer compared to healthy controls

Breast (Edinburgh), 2016-08, Vol.28, p.100-106

2016

Link zum Volltext

Verfügbarkeit prüfen

Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database

Breast cancer research and treatment, 2019-08, Vol.177 (1), p.185-195

2019

Link zum Volltext

Verfügbarkeit prüfen

Ivar Guldvog

Tidsskrift for den Norske Lægeforening, 2021

Søiland, Håvard

2021

Link zum Volltext

Verfügbarkeit prüfen

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers

Breast cancer research and treatment, 2009-05, Vol.115 (2), p.241-254

2009

Link zum Volltext

Verfügbarkeit prüfen

The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells

PloS one, 2015-04, Vol.10 (4), p.e0122339-e0122339

2015

Link zum Volltext

Verfügbarkeit prüfen

Diet in women with breast cancer compared to healthy controls – What is the difference?

European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2018-02, Vol.32, p.20-24

2018

Link zum Volltext

Verfügbarkeit prüfen

Our genes, our selves: hereditary breast cancer and biological citizenship in Norway

Medicine, health care, and philosophy, 2017-03, Vol.20 (1), p.89-103

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(66)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Predictors of adherence and the role of primary non-adherence in antihormonal treatment of breast cancer

Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies

Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review

The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial

Generating a Precision Endoxifen Prediction Algorithm to Advance Personalized Tamoxifen Treatment in Patients with Breast Cancer

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study

Thyroidectomy for Euthyroid Patients with Hashimoto Disease and Persistent Symptoms: An Observational, Postrandomization Study

Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen

Biologic profiling of lymph node negative breast cancers by means of microRNA expression

Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients

Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort

Illness uncertainty in breast cancer patients: Validation of the 5-item short form of the Mishel Uncertainty in Illness Scale

Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial

Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment

In Patients Younger Than Age 55 Years With Lymph Node–Negative Breast Cancer, Proliferation by Mitotic Activity Index Is Prognostically Superior to Adjuvant

Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients

Fatigue, anxiety and depression overrule the role of oncological treatment in predicting self-reported health complaints in women with breast cancer compared to healthy controls

Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database

Ivar Guldvog

Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers

The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells

Diet in women with breast cancer compared to healthy controls – What is the difference?

Our genes, our selves: hereditary breast cancer and biological citizenship in Norway

Suchergebnisse filtern